These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38184142)

  • 1. A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
    Song WB; Garshick MS; Barbieri JS; Shin DB; Báez S; Papadopoulos M; Neopaney A; Fitzsimmons R; Kalb RE; Mease PJ; Craig ET; Koplin J; Takeshita J; Chiesa Fuxench ZC; Armstrong AW; Mehta NN; Beidas RS; Ogdie AR; Gelfand JM
    J Invest Dermatol; 2024 Jun; 144(6):1405-1409.e1. PubMed ID: 38184142
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
    Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care-based screening for cardiovascular risk factors in patients with psoriasis.
    Rutter MK; Kane K; Lunt M; Cordingley L; Littlewood A; Young HS; Chew-Graham CA; Hilton R; Symmons DP; Griffiths CE
    Br J Dermatol; 2016 Aug; 175(2):348-56. PubMed ID: 26990294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis.
    Eder L; Dey A; Joshi AA; Boehncke WH; Mehta NN; Szentpetery A
    J Rheumatol Suppl; 2019 Jun; 95():20-27. PubMed ID: 31154400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease.
    Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M
    J Dermatol; 2013 Nov; 40(11):923-6. PubMed ID: 24128349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease.
    Barbieri JS; Beidas RS; Gondo GC; Fishman J; Williams NJ; Armstrong AW; Ogdie AR; Mehta N; Gelfand JM
    JAMA Dermatol; 2022 Mar; 158(3):252-259. PubMed ID: 35044419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Charlot M; Jørgensen CH; Lindhardsen J; Olesen JB; Abildstrøm SZ; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Aug; 270(2):147-57. PubMed ID: 21114692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study.
    Charlton R; Green A; Shaddick G; Snowball J; Nightingale A; Tillett W; Smith C; McHugh N;
    Rheumatology (Oxford); 2019 Jan; 58(1):144-148. PubMed ID: 30202906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.
    Chiu HY; Chang WL; Huang WF; Wen YW; Tsai YW; Tsai TF
    J Am Acad Dermatol; 2015 Sep; 73(3):429-38. PubMed ID: 26188627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
    Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 30-year cardiovascular disease risk in psoriatic population.
    Buligan C; Donati F; Stinco G
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):e516-e517. PubMed ID: 28556963
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.